Refractive changes during immunotherapy: Think diabetes!

Erwin Benassaia; Jean Pierre Riveline; Emilie Routier; Emmanuel Barreau; Caroline Robert

doi:10.1016/j.ejca.2021.07.047

Refractive changes during immunotherapy: Think diabetes!

Erwin Benassaia, Jean Pierre Riveline, Emilie Routier, Emmanuel Barreau, Caroline Robert

Résultats de recherche: Contribution à un journal › Letter › Revue par des pairs

langue originale	Anglais
Pages (de - à)	15-16
Nombre de pages	2
journal	European Journal of Cancer
Volume	158
Les DOIs	https://doi.org/10.1016/j.ejca.2021.07.047
état	Publié - 1 nov. 2021

Accès au document

10.1016/j.ejca.2021.07.047

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{ec273f251c094403bdd1bcf1d8dcddf0,

title = "Refractive changes during immunotherapy: Think diabetes!",

author = "Erwin Benassaia and Riveline, {Jean Pierre} and Emilie Routier and Emmanuel Barreau and Caroline Robert",

note = "Funding Information: J.-P.R. is an advisory panel member for Sanofi, MSD, Eli Lilly, Novo Nordisk, Abbott, Alphadiab, Air Liquide and Medtronic and has received research funding from and provided research support to Abbott, Air Liquide, Sanofi, and Novo Nordisk. ",

year = "2021",

month = nov,

day = "1",

doi = "10.1016/j.ejca.2021.07.047",

language = "English",

volume = "158",

pages = "15--16",

journal = "European Journal of Cancer",

issn = "0959-8049",

}

TY - JOUR

T1 - Refractive changes during immunotherapy

T2 - Think diabetes!

AU - Benassaia, Erwin

AU - Riveline, Jean Pierre

AU - Routier, Emilie

AU - Barreau, Emmanuel

AU - Robert, Caroline

N1 - Funding Information: J.-P.R. is an advisory panel member for Sanofi, MSD, Eli Lilly, Novo Nordisk, Abbott, Alphadiab, Air Liquide and Medtronic and has received research funding from and provided research support to Abbott, Air Liquide, Sanofi, and Novo Nordisk.

PY - 2021/11/1

Y1 - 2021/11/1

UR - http://www.scopus.com/inward/record.url?scp=85116599271&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2021.07.047

DO - 10.1016/j.ejca.2021.07.047

M3 - Letter

AN - SCOPUS:85116599271

SN - 0959-8049

VL - 158

SP - 15

EP - 16

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -